- $1.2 BnWorld market, 2023
- $4.3 BnProjected, 2033
- 13.7%Growth a year (CAGR)
- 2,212Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$504 Mn
11.7% a year · 42% of the world -
2
China
$97 Mn
15.2% a year · 8% of the world -
3
Canada
$96 Mn
13.7% a year · 8% of the world -
4
Japan
$75 Mn
14.2% a year · 6.2% of the world -
5
Germany
$44 Mn
11.9% a year · 3.7% of the world -
6
France
$33 Mn
12.7% a year · 2.8% of the world -
7
UK
$31 Mn
11.7% a year · 2.6% of the world -
8
Brazil
$30 Mn
14.7% a year · 2.5% of the world -
9
Italy
$29 Mn
13.2% a year · 2.4% of the world -
10
Ecuador
$24 Mn
14.3% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
SpainDigital Pathology Systems by country and region
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Egypt
Philippines
Hong Kong
Malaysia
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 6,165 papers since 2021
- Who helped read the slide? Patient disclosure in AI-assisted pathology. Journal of clinical pathology, 2026
- Prior-guided whole-slide survival prediction with soft histopathologic priors from vision-language foundation models. Biomedical physics & engineering express, 2026
- Evaluating JPEG2000 compression effects on prediction accuracy and storage efficiency in lung cancer whole-slide images: a deep learning-based analysis. Diagnostic pathology, 2026
- Impact of data quality on deep learning prediction of spatial transcriptomics from histology images. Genome biology, 2026
- Improving the Quality of Care in Advanced Prostate Cancer Through Personalised Diagnostic Testing. Outcomes of a Sharing Progress in Cancer Care taskforce conducted under the auspices of the European Association of Urology. Critical reviews in oncology/hematology, 2026
Compare Digital Pathology Systems side by side
Key companies in Digital Pathology Systems
Leica Biosystems
Philips Healthcare
Hamamatsu Photonics
Roche Diagnostics
Ventana Medical Systems (a Roche company)
3DHISTECH Ltd.
Apollo Enterprise Imaging Corp.
XIFIN, Inc.
Huron Digital Pathology
Visiopharm A/S
Quick answers
How big is the Digital Pathology Systems market?
The world Digital Pathology Systems market was worth about $1.2 Bn in 2023 and is projected to reach $4.3 Bn by 2033, growing 13.7% a year (CAGR).
Which country has the largest Digital Pathology Systems market?
The US is the largest of the 24 countries we cover, at $504 Mn in 2023. India grows fastest, at 16.7% a year.
How many clinical trials are running in Digital Pathology Systems?
ClinicalTrials.gov lists 2,212 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Digital Pathology Systems?
PubMed lists about 6,165 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.